Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; ''ecstasy'')

被引：28
|
作者：
Cohen, RS
机构：
[1] Research Department, Peapack, NJ
[2] Research Department, Peapack, NJ 07977
来源：
BIOLOGICAL PSYCHIATRY | 1996年 / 39卷 / 09期
关键词：
ecstasy; MDMA; drug use; serotonin; suicide;
D O I：
10.1016/0006-3223(95)00551-X
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：819 / 820
页数：2
相关论文
共 50 条
  • [31] Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence
    R. I. Dafters
    Frances Duffy
    Patrick J. O’Donnell
    Caroline Bouquet
    Psychopharmacology, 1999, 145 : 82 - 90
  • [32] Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence
    Dafters, RI
    Duffy, F
    O'Donnell, PJ
    Bouquet, C
    PSYCHOPHARMACOLOGY, 1999, 145 (01) : 82 - 90
  • [33] DIVERSITY OF PSYCHOPATHOLOGY ASSOCIATED WITH USE OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (ECSTASY)
    MCGUIRE, PK
    COPE, H
    FAHY, TA
    BRITISH JOURNAL OF PSYCHIATRY, 1994, 165 : 391 - 395
  • [34] Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms
    MacInnes, N
    Handley, SL
    Harding, GFA
    JOURNAL OF PSYCHOPHARMACOLOGY, 2001, 15 (03) : 181 - 186
  • [35] Demographic and health characteristics of 3,4-methylenedioxymethamphetamine users (MDMA, ecstasy)
    Wieckiewicz, Gniewko
    Danel, Dariusz
    Piegza, Magdalena
    Gorczyca, Piotr
    Pudlo, Robert
    PSYCHIATRIA POLSKA, 2022, 56 (05) : 1109 - 1130
  • [36] 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, 'ECSTASY'): GENDER DIFFERENCES IN PHARMACOKINETICS AND PHARMACODYNAMICS
    Pardo-Lozano, R.
    Farre, M.
    Yubero-Lahoz, S.
    Torrens, M.
    Mustata, C.
    Perez-Mana, C.
    Menoyo, E.
    Perez, M.
    Martin, S.
    Cuyas, E.
    Civit, E.
    O'Mathuna, B.
    Carbo, M.
    de la Torre, R.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 51 - 52
  • [37] Methylenedioxymethamphetamine (MDMA; "Ecstasy") suppresses the primary IgG response to an antigenic challenge in rats
    Connor, TJ
    Connelly, DB
    Kelly, JP
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134
  • [38] Methylenedioxymethamphetamine (MDMA, 'ecstasy') serves as a robust positive reinforcer in a rat runway procedure
    Wakionigg, G
    Strum, K
    Saria, A
    Zernig, G
    PHARMACOLOGY, 2003, 69 (04) : 180 - 182
  • [39] Modelling the adverse effects associated with ecstasy use
    Fisk, John E.
    Murphy, Philip N.
    Montgomery, Catharine
    Hadjiefthyvoulou, Florentia
    ADDICTION, 2011, 106 (04) : 798 - 805
  • [40] Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users
    Back-Madruga, C
    Boone, KB
    Chang, L
    Grob, CS
    Lee, A
    Nations, H
    Poland, RE
    CLINICAL NEUROPSYCHOLOGIST, 2003, 17 (04) : 446 - 459
12345